SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : A Luxury Resort for the ill -- Medical Resorts Intl.TRAC -- Ignore unavailable to you. Want to Upgrade?


To: swot who wrote (959)1/20/1999 2:26:00 AM
From: swot  Respond to of 1126
 
Interesting, I notice FATHERSTOCK has stopped posting on this thread and has also changed his name to TOPCAT1. hmmmmm



To: swot who wrote (959)1/20/1999 8:48:00 AM
From: 24karat  Respond to of 1126
 
Thankyou Marty, To say the least, after reading your post. It scares the SH*T out of me. In doing more reaserch, it wuld be nice if someone could locate the clinic that was recently purchased in Vancouver. Find and post the address, phone #,names of Manager, Doctors,if any. And ask who owns the clinic.This would be easier to do if you lived in Van. I hope we're not being taken for a ride.



To: swot who wrote (959)1/20/1999 9:27:00 AM
From: Saverio  Read Replies (1) | Respond to of 1126
 
Thanks for your post, Marty. I understand why you have mixed feelings, and your post is not exactly what I like to read. It seems to me that the final stages of preparation mean different things to different people. I was at the shareholders meeting and he was asked what happened to all the clinics that had been planned about a year ago; his answer was that the strategy was changed because creating dialysis clinics from nothing required significant amounts of cash to be spent before the first client gets in the door. Their strategy will therefore be to acquire chelation clinics which are already generating cash and to add dialysis to them at a much lower cost; as both types of procedures are similar (both I.V. treatments) it is more efficient from a staff training point of view.
With respect to Guidera, while he did not specifically mention the name, when asked about the share price, he indicated that he would hire I.R. help, but would not go back to promoters (my reading: Guidera) who ask an exorbitant price in cash and shares and do not do much nor produce much results. They will try to get into more investment newsletters.
I can't say I disagree with Rob's new strategy re chelation/dialysis. It makes sense to me. I wish only he would get more straigthforward when communicating the status of his plans, or changes in his plans.
I will be keenly watching financial results as they come out, to determine whether they come out as planned.
Saverio